NAMS
Price
$18.21
Change
-$0.17 (-0.92%)
Updated
Apr 2 closing price
Capitalization
2B
34 days until earnings call
WXXWY
Price
$6.85
Change
-$0.08 (-1.15%)
Updated
Apr 1 closing price
Capitalization
13.82B
56 days until earnings call
Ad is loading...

NAMS vs WXXWY

Header iconNAMS vs WXXWY Comparison
Open Charts NAMS vs WXXWYBanner chart's image
NewAmsterdam Pharma
Price$18.21
Change-$0.17 (-0.92%)
Volume$1.43M
Capitalization2B
Wuxi Biologics (Cayman)
Price$6.85
Change-$0.08 (-1.15%)
Volume$51.12K
Capitalization13.82B
NAMS vs WXXWY Comparison Chart
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. WXXWY commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and WXXWY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (NAMS: $18.38 vs. WXXWY: $6.85)
Brand notoriety: NAMS and WXXWY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 258% vs. WXXWY: 115%
Market capitalization -- NAMS: $2B vs. WXXWY: $13.82B
NAMS [@Biotechnology] is valued at $2B. WXXWY’s [@Biotechnology] market capitalization is $13.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileWXXWY’s FA Score has 1 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • WXXWY’s FA Score: 1 green, 4 red.
According to our system of comparison, WXXWY is a better buy in the long-term than NAMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 6 TA indicator(s) are bullish while WXXWY’s TA Score has 3 bullish TA indicator(s).

  • NAMS’s TA Score: 6 bullish, 4 bearish.
  • WXXWY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than WXXWY.

Price Growth

NAMS (@Biotechnology) experienced а -23.42% price change this week, while WXXWY (@Biotechnology) price change was +2.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.27%. For the same industry, the average monthly price growth was -7.37%, and the average quarterly price growth was -12.08%.

Reported Earning Dates

NAMS is expected to report earnings on May 07, 2025.

WXXWY is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-5.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WXXWY($13.8B) has a higher market cap than NAMS($2B). WXXWY YTD gains are higher at: 54.715 vs. NAMS (-29.144).
NAMSWXXWYNAMS / WXXWY
Capitalization2B13.8B14%
EBITDA-241.49MN/A-
Gain YTD-29.14454.715-53%
P/E RatioN/A31.45-
Revenue45.6MN/A-
Total Cash834MN/A-
Total Debt448KN/A-
FUNDAMENTALS RATINGS
WXXWY: Fundamental Ratings
WXXWY
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
61
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSWXXWY
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bearish Trend 2 days ago
42%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
54%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
71%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WXXWY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSCNX15.13N/A
N/A
Fidelity Advisor Asset Manager 60% C
ASICX23.15N/A
N/A
Invesco EQV Asia Pacific Equity C
JGSRX12.03N/A
N/A
JHancock Global Shareholder Yield R2
SSMHX288.16N/A
N/A
State Street Small/Mid Cap Equity Index
BSCMX15.88N/A
N/A
Brandes Small Cap Value I

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-0.92%
QURE - NAMS
51%
Loosely correlated
+7.16%
CMRX - NAMS
50%
Loosely correlated
+0.24%
CRDF - NAMS
34%
Loosely correlated
-1.63%
GYRE - NAMS
32%
Poorly correlated
+10.61%
CGON - NAMS
29%
Poorly correlated
+0.86%
More

WXXWY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WXXWY has been loosely correlated with WXIBF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if WXXWY jumps, then WXIBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WXXWY
1D Price
Change %
WXXWY100%
-1.15%
WXIBF - WXXWY
46%
Loosely correlated
N/A
ONC - WXXWY
36%
Loosely correlated
-0.42%
SNBIF - WXXWY
28%
Poorly correlated
N/A
NAMS - WXXWY
23%
Poorly correlated
-10.21%
ZLAB - WXXWY
23%
Poorly correlated
+3.18%
More